Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

63.65
Delayed Data
As of Oct 16
 -1.64 / -2.51%
Today’s Change
46.01
Today|||52-Week Range
66.10
+8.92%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Operating ActivitiesNet Income / Starting Line1.2B898.0M1.5B922.0M
 
 
 
 
 
Depreciation105.0M122.0M193.0M211.0M
 
 
 
 
 
Total Other Cash Flow-58.0M43.0M-68.0M381.0M
 
 
 
 
 
Funds From Operations1.1B1.4B1.6B1.6B
 
 
 
 
 
Funds From/For Other Operating Expenses-318.0M-69.0M720.0M21.0M
 
 
 
 
 
Net Cash Flow - Operating Activities1.4B1.4B861.0M1.6B
 
 
 
 
 
 
InvestingIncrease In Investments-1.1B-841.0M-1.2B-1.8B
 
 
 
 
 
Decrease In Investments880.0M1.1B1.2B1.1B
 
 
 
 
 
Capital Expenditures-341.0M-371.0M-291.0M-248.0M
 
 
 
 
 
Fixed Asset Disposal190.0M141.0M241.0M148.0M
 
 
 
 
 
Net Assets From Acquisitions -44.0M-48.0M-112.0M-207.0M
 
 
 
 
 
Net Cash Flow Investing-368.0M16.0M-203.0M-1.0B
 
 
 
 
 
 
FinancingShort Term Borrowings85.0M23.0M192.0M108.0M
 
 
 
 
 
Long Term Borrowings0.000.001.5B0.00
 
 
Long Term Debt Reduction0.00-15.0M----
 
 
Net Proceeds Stock Sale12.0M37.0M0.000.00
 
 
 
Common Preferred Redeemed0.000.00-2.0B0.00
 
 
Common Dividends----------
Cash Dividends Paid - Total-636.0M-635.0M-655.0M-643.0M
 
 
 
 
 
Other Sources - Financing0.0042.0M----
 
 
Other Uses - Financing0.00--38.0M-3.0M
 
 
 
Net Cash Flow - Financing-539.0M-590.0M-1.0B-1.0B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash8.0M-49.0M28.0M6.0M
 
 
 
 
 
 
Net Change In Cash490.0M854.0M-355.0M-446.0M